NanoString Technologies Inc
NASDAQ:NSTG
Intrinsic Value
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. [ Read More ]
The intrinsic value of one
NSTG
stock under the Base Case scenario is
10.9444
USD.
Compared to the current market price of 0.1053 USD,
NanoString Technologies Inc
is
Undervalued by 99%.
NanoString Technologies Inc's market capitalization is 8.9m USD.
NSTG stock price is 0.1053 USD.
NSTG stock price (0.1053 USD) is 99% less than its Intrinsic Value (10.9444 USD).
NSTG. Open DCF Valuation
NSTG stock price (0.1053 USD) is 99% less than its Relative Value (10.9444 USD). Open Relative Valuation
NSTG.
NSTG's Revenue has grown by an exceptional 20% over the past 12 months.
NSTG's Revenue has been growing by 11% per year for the last 3 years.
NSTG has positive Net Debt. This means that the company has more debt (228m USD) than cash and short-term investments (97m USD).
NSTG's long-term liabilties (325m USD) exceed its long-term assets (275m USD).
NSTG's ROE (Return on Equity) has significantly decreased in the last 3 years from -53% to -1 031%, and is approaching profitability.
NSTG's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -90% to -116%, and is approaching profitability.
NSTG has negative Operating Income for the last twelve months.
NSTG has negative Net Income for the last twelve months.
NSTG's ROE (Return on Equity) for the past 12 months is negative and is equal to -1 031%.
NSTG's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -116%.
NSTG has positive Gross Profit for the last twelve months.
NSTG's short-term assets (212m USD) exceed its short-term liabilties (78m USD).
NSTG has negative Free Cash Flow for the last twelve months.
NSTG has negative three-year average ROE (Return on Equity): -181%. The company is not efficient at transforming stockholders' equity into net income.
NSTG has negative three-year average ROIC (Return on Invested Capital): -106%. The company is not efficient at using invested capital to generate operating income.
NSTG's D/E (Debt to Equity) is very low and is equal to -4.5.
NSTG's Altman Z-Score is very low and is equal to -5.68.
Fundamental Analysis
NanoString Technologies Inc
Balance Sheet Decomposition
NanoString Technologies Inc
| Current Assets | 211.8m |
| Cash & Short-Term Investments | 97.1m |
| Receivables | 48.4m |
| Other Current Assets | 66.3m |
| Non-Current Assets | 62.9m |
| PP&E | 59.4m |
| Other Non-Current Assets | 3.5m |
| Current Liabilities | 77.5m |
| Accounts Payable | 33.3m |
| Accrued Liabilities | 29.7m |
| Other Current Liabilities | 14.5m |
| Non-Current Liabilities | 247.8m |
| Long-Term Debt | 227.8m |
| Other Non-Current Liabilities | 20m |
Earnings Waterfall
NanoString Technologies Inc
|
Revenue
|
162.5m
USD
|
|
Cost of Revenue
|
-104.5m
USD
|
|
Gross Profit
|
58m
USD
|
|
Operating Expenses
|
-220.6m
USD
|
|
Operating Income
|
-162.6m
USD
|
|
Other Expenses
|
-3.8m
USD
|
|
Net Income
|
-166.4m
USD
|
Free Cash Flow Analysis
NanoString Technologies Inc
NSTG Profitability Score
Profitability Due Diligence
NanoString Technologies Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
Score
NanoString Technologies Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
NSTG Solvency Score
Solvency Due Diligence
NanoString Technologies Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
NanoString Technologies Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSTG Price Targets Summary
NanoString Technologies Inc
Ownership
NSTG Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
NSTG Price
NanoString Technologies Inc
| Average Annual Return | 6.84% |
| Standard Deviation of Annual Returns | 93.22% |
| Max Drawdown | -100% |
| Market Capitalization | 8.9m USD |
| Shares Outstanding | 84 447 616 |
| Percentage of Shares Shorted | 16.67% |
Company Profile
NanoString Technologies Inc
Country
Industry
Market Cap
Dividend Yield
Description
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 766 full-time employees. The company went IPO on 2013-06-26. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. The company uses its core technology to develop tools for scientific and clinical research. The company offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.
You don't have any saved screeners yet
